Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 286 AL 300

Alzheimer's Disease: A Silent Pandemic - A Systematic Review on the Situation and Patent Landscape of the Diagnosis

Goyzueta-Mamani LD, Chávez-Fumagalli MA, Alvarez-Fernandez K, Aguilar-Pineda JA, Nieto-Montesinos R, Davila Del-Carpio G, Vera-Lopez KJ, Lino Cardenas CL.

Recent Pat Biotechnol. 2022;16(4):355-378. doi: 10.2174/1872208316666220408114129.

Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants

Mozersky J, Roberts JS, Rumbaugh M, Chhatwal J, Wijsman E, Galasko D, Blacker D; AGREED.

J Alzheimers Dis. 2022;90(3):1035-1043. doi: 10.3233/JAD-220113.

α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease

Beatino MF, De Luca C, Campese N, Belli E, Piccarducci R, Giampietri L, Martini C, Perugi G, Siciliano G, Ceravolo R, Vergallo A, Hampel H, Baldacci F.

Expert Rev Mol Diagn. 2022 Apr;22(4):411-425. doi: 10.1080/14737159.2022.2068952. Epub 2022 May 6.

Advances in the development of new biomarkers for Alzheimer's disease

Klyucherev TO, Olszewski P, Shalimova AA, Chubarev VN, Tarasov VV, Attwood MM, Syvänen S, Schiöth HB.

Transl Neurodegener. 2022 Apr 21;11(1):25. doi: 10.1186/s40035-022-00296-z.

Current trends in blood biomarker detection and imaging for Alzheimer's disease

Hu S, Yang C, Luo H.

Biosens Bioelectron. 2022 Aug 15;210:114278. doi: 10.1016/j.bios.2022.114278. Epub 2022 Apr 12.

Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

Botto R, Callai N, Cermelli A, Causarano L, Rainero I.

Neurol Sci. 2022 Jul;43(7):4107-4124. doi: 10.1007/s10072-022-06068-x. Epub 2022 Apr 23.

Blood biomarkers for Alzheimer's disease and related disorders

Zetterberg H, Schott JM.

Acta Neurol Scand. 2022 Jul;146(1):51-55. doi: 10.1111/ane.13628. Epub 2022 Apr 25.

Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis

Custodero C, Ciavarella A, Panza F, Gnocchi D, Lenato GM, Lee J, Mazzocca A, Sabbà C, Solfrizzi V.

Geroscience. 2022 Jun;44(3):1373-1392. doi: 10.1007/s11357-022-00556-w. Epub 2022 Apr 29.

Brain ventricles, CSF and cognition: a narrative review

de Mélo Silva Júnior ML, Diniz PRB, de Souza Vilanova MV, Basto GPT, Valença MM.

Psychogeriatrics. 2022 Jul;22(4):544-552. doi: 10.1111/psyg.12839. Epub 2022 Apr 30.

How to use neuroimaging biomarkers in the diagnosis framework of neurodegenerative diseases?

Chételat G.

Rev Neurol (Paris). 2022 May;178(5):490-497. doi: 10.1016/j.neurol.2022.03.006. Epub 2022 Apr 30.

Biomarkers for Alzheimer's Disease in the Current State: A Narrative Review

Gunes S, Aizawa Y, Sugashi T, Sugimoto M, Rodrigues PP.

Int J Mol Sci. 2022 Apr 29;23(9):4962. doi: 10.3390/ijms23094962.

Lactoferrin of oral fluid is normal and in Alzheimer's disease: laboratory and diagnostic aspects (review of literature)

Bazarnyi VV, Sidenkova AP, Sosnin DY.

Klin Lab Diagn. 2022 Apr 17;67(4):207-212. doi: 10.51620/0869-2084-2022-67-4-207-212.

Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

Karikari TK, Ashton NJ, Brinkmalm G, Brum WS, Benedet AL, Montoliu-Gaya L, Lantero-Rodriguez J, Pascoal TA, Suárez-Calvet M, Rosa-Neto P, Blennow K, Zetterberg H.

Nat Rev Neurol. 2022 Jul;18(7):400-418. doi: 10.1038/s41582-022-00665-2. Epub 2022 May 18.

Peripheral Inflammatory Biomarkers of Alzheimer's Disease

Hao J, Guo Y, Guo K, Yang Q.

J Alzheimers Dis. 2022;88(2):389-398. doi: 10.3233/JAD-215422.

Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults

Wittfeld K, Raman MR, Conner SC, Aslam A, Teumer A, Nauck M, Hosten N, Habes M, DeCarli C, Vasan RS, Beiser AS, Himali JJ, Seshadri S, Grabe HJ, Satizabal CL.

J Alzheimers Dis. 2022;88(1):311-322. doi: 10.3233/JAD-220356.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias